Trametinib Tx Shows Promise in Tough-to-Treat LGSOC Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
Data Support 'Best Drug First' in EGFR-Mutant NSCLC Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
PARP Inhibitors: The Key to a Tx Paradigm Shift in Ovarian Ca? PRIMA and VELIA trial findings advance niraparib and veliparib to the therapeutic front lines Sep 29, 2019
Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
First-Line Combo Boosts PFS in Advanced Ovarian Ca Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
Advanced HCC Trial Misses OS Endpoint But CheckMate 459 researchers tout "encouraging efficacy and favorable safety profile" Sep 28, 2019
Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
BCG Vax: A Shot Against Lung Cancer in Native Populations? 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
Ibrutinib's Cardiotoxicity Comes Into Focus Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
How Often Does MRI Miss the Mark in Prostate Ca? Retrospective study finds 21% of patients with prostate cancer pathology did not have ROI on MRI Sep 25, 2019
Red Cell Distribution Width Strongly Predicts Hip Fracture Simple way to identify at-risk patients Sep 24, 2019
Wires or RFID Tags in Breast Cancer Excision? Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
ASTRO Unveils First RT Guideline for Pancreatic Cancer Radiation's role in pancreatic cancer is "controversial," says guideline author Sep 23, 2019
H. Pylori Found in Sleeve Gastrectomy Specimens Incidental findings can have important clinical implications in obese patients Sep 23, 2019
Tx Deintensification Wins in Head and Neck Cancer, But ... Only against another less-intensive approach in HPV-positive disease Sep 18, 2019
Could Mom's Anemia Hurt Baby's Brain? Association study suggests an increased risk, though still quite small Sep 18, 2019
Gandalf the Grey, the Wizard of Omaha, and Prostate Cancer High-profile celebs and low-risk disease Sep 18, 2019
Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
Consider PSA Before Adding ADT to Salvage Radiation Men with levels below 0.6 ng/mL show no benefit, at risk of other-cause mortality Sep 16, 2019
Medical Marijuana Overdose Sends Man to ER Case report highlights risks of high-strength THC products in patients' hands Sep 12, 2019
Good News, Bad News for CRISPR Gene Editing for HIV Cure "Bigger story for the gene-editing field than the HIV field" Sep 11, 2019
Anti-PD-1/L1 for NSCLC Sparks Talk of the 'C' Word Unprecedented survival at 3 and 5 years, but investigators reluctant to say "cure" Sep 10, 2019
'Dirtier' Drugs Step Aside in RET-Positive NSCLC Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
TMB in Lung Cancer: 'Not Ready for Prime Time' No association between tumor mutational burden and outcomes in three trials Sep 09, 2019
The Legacy of Henry Lynch, MD Earlier this summer the legendary researcher passed, his contributions to cancer research are immeasurable Sep 01, 2019
Mystery! The Vanishing Prostate Tumor Do cancers really disappear spontaneously? Or are they just eluding us? Aug 23, 2019
Olivia Newton-John's Stage 4 Cancer Cannabis Management The singer and actress updates fans on her battle, but can marijuana help? Aug 22, 2019
When Medicare Stops Covering a Test Without Warning Why didn't someone tell me, asks Hans Duvefelt, MD Aug 20, 2019
Newer Prostate Cancer Agents Not Free of Heart Risk Patients with three or more cardiac conditions were at highest risk of early death Aug 14, 2019
Study: Scale Back Surveillance for HPV Oropharyngeal Cancers Retrospective data show no survival advantage with adherence to NCCN guidelines Aug 13, 2019
Gadzooks! And Egads! Another Dilemma in Prostate Cancer Gadolinium scans present yet another thorny decision for patients on active surveillance Jul 28, 2019
MRI Screening Finds More Breast Cancers, but at What Cost? Even breast cancer survivors may find it tough to sort out benefits and harms Jul 24, 2019
Serum Immune Markers May Predict Conversion From MGUS to Myeloma Results could support annual blood tests and risk assessment for those with MGUS and its subtype, light-chain MGUS Jul 19, 2019
Why Are These Bones and Teeth Where They Shouldn't Be? Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain Jul 12, 2019
Small Cancer Risk With Lung Micronodules Supports classifying small nodules as negative scan result Jul 10, 2019
